HMGI(Y) gene expression in colorectal cancer:: Comparison with some histological typing, grading, and clinical staging

被引:25
|
作者
Balcerczak, M
Pasz-Walczak, G
Balcerczak, E
Wojtylak, M
Kordek, R
Mirowski, M
机构
[1] Med Univ Lodz, Dept Pharmaceut Biochem, Mol Biol Lab, Fac Pharm, PL-90151 Lodz, Poland
[2] Med Univ Lodz, Dept Tumor Pathol, Lodz, Poland
关键词
colorectal cancer; HMGI(Y) gene;
D O I
10.1078/0344-0338-00475
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
investigated HMGI(Y) gene expression in 81 pairs of frozen samples obtained from colorectal carcinomas and adjacent normal colorectal mucosas and in four samples from colorectal mucosa from patients without neoplastic diseases. In this group, HMGI(Y)-positive/-negative expression was compared with some histological features, grading, and clinical staging of neoplasms investigated to assess its potential role as a prognostic marker for colorectal cancer. Expression of HMGI(Y) gene was found in 51 of 81 cases of colorectal cancers, while, in normal mucosa, expression of this gene was not observed. HMGI(Y) gene expression was associated with more advanced tumors (T3, T4) and metastases to lymph nodes (N1, N2). The most interesting finding was that expression of this gene correlated with distant metastases. HMGI(Y) gene expression was detected in all cases classified as M1 (n = 19, p = 0.0008). We did not find any association between age, gender, tumor localization, histological type and this gene expression.
引用
收藏
页码:641 / 646
页数:6
相关论文
共 50 条
  • [31] Non-small cell lung cancer histological sub-typing by gene expression analysis from FFPE tissue
    Wang, Eva
    Lu, Zhenqiang
    Moddula, Krishna
    Schwartz, Mark
    Roberts, Chris
    Joshi, Mary-Beth
    Harpole, David
    Modur, Vijay
    CANCER RESEARCH, 2014, 74 (19)
  • [32] Clock Gene Expression Levels and Relationship With Clinical and Pathological Features in Colorectal Cancer Patients
    Mazzoccoli, G.
    Panza, A.
    Valvano, M. R.
    Palumbo, O.
    Carella, M.
    Pazienza, V.
    Biscaglia, G.
    Tavano, F.
    Di Sebastiano, P.
    Andriulli, A.
    Piepoli, A.
    CHRONOBIOLOGY INTERNATIONAL, 2011, 28 (10) : 841 - 851
  • [33] Metalloproteinases and colorectal cancer. Correlation of gene expression and clinical-pathological parameters
    Morini, Sandra Regina
    Denadai, Marcos Vinicius
    Waisberg, Jaques
    Lopes Filho, Gaspar de Jesus
    Matos, Delcio
    Saad, Sarhan Sydney
    ACTA CIRURGICA BRASILEIRA, 2020, 35 (07) : 1 - 7
  • [34] Clinical relevance and function of HMGB1 gene polymorphism and expression in colorectal cancer
    Wang, Fang
    Huang, Zhijun
    Li, Jianping
    Gao, Xueren
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2024,
  • [35] Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer
    Cavalieri, Duccio
    Dolara, Piero
    Mini, Enrico
    Luceri, Cristina
    Castagnini, Cinzia
    Toti, Simona
    Maciag, Karolina
    De Filippo, Carlotta
    Nobili, Stefania
    Morganti, Maria
    Napoli, Cristina
    Tonini, Giulia
    Baccini, Michela
    Biggeri, Annibale
    Tonelli, Francesco
    Valanzano, Rosa
    Orlando, Claudio
    Gelmini, Stefania
    Cianchi, Fabio
    Messerini, Luca
    Luzzatto, Lucio
    ONCOLOGY RESEARCH, 2007, 16 (11) : 535 - 548
  • [36] Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer
    Ogawa, K
    Utsunomiya, T
    Mimori, K
    Tanaka, F
    Inoue, H
    Nagahara, H
    Murayama, S
    Mori, M
    CLINICAL CANCER RESEARCH, 2005, 11 (08) : 2889 - 2893
  • [37] Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
    Graziano, F.
    Ruzzo, A.
    Giacomini, E.
    Ricciardi, T.
    Aprile, G.
    Loupakis, F.
    Lorenzini, P.
    Ongaro, E.
    Zoratto, F.
    Catalano, V.
    Sart, D.
    Rulli, E.
    Cremolini, C.
    De Nictolis, M.
    De Maglio, G.
    Falcone, A.
    Fiorentinil, G.
    Magnani, M.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (03): : 258 - 264
  • [38] Glycolysis gene expression analysis and selective metabolic advantage in the clinical progression of colorectal cancer
    F Graziano
    A Ruzzo
    E Giacomini
    T Ricciardi
    G Aprile
    F Loupakis
    P Lorenzini
    E Ongaro
    F Zoratto
    V Catalano
    D Sarti
    E Rulli
    C Cremolini
    M De Nictolis
    G De Maglio
    A Falcone
    G Fiorentini
    M Magnani
    The Pharmacogenomics Journal, 2017, 17 : 258 - 264
  • [39] Clinical relevance of immune microenvironment and gene-expression-based biomarkers in colorectal cancer
    Rallo, Vincenzo
    Massidda, Matteo
    Wen, Xiaofen
    Shen, Jiaxin
    Deiana, Manila
    Maschio, Andrea
    Scanu, Antonio Mario
    De Miglio, Maria Rosaria
    Angius, Andrea
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2024, 32 : 907 - 907
  • [40] A Comparison of Clinical-Radiological and Pathological Colorectal Cancer Staging: A Six Year Model 3 Irish Hospital Experience
    Elfaedy, O.
    Owens, P.
    Aakif, M.
    Mansour, E.
    BRITISH JOURNAL OF SURGERY, 2018, 105 : 153 - 153